Financials
Value Q1, 25Q2, 25Q3, 25Q4, 25Q1, 26 TTM Selling/general/admin expenses 204.45 K152.68 K113.42 K118.56 K183.2 K 567.86 K Research & development ————— — Operating income -204.45 K-152.68 K-113.42 K-118.56 K-183.2 K -567.86 K Non-Operating Income, Total 1.19 M1.59 M1.61 M1.51 M1.38 M 6.09 M Interest expense, net of interest capitalized ————— — Non-Operating Income, excl. Interest Expenses 1.19 M1.59 M1.61 M1.51 M1.38 M 6.09 M Unusual income/expense ————— — Pretax income 981.03 K1.44 M1.5 M1.39 M1.2 M 5.53 M Equity in earnings ————— — Taxes ————— — Non-controlling/minority interest ————— — After tax other income/expense ————— — Net income before discontinued operations 981.03 K1.44 M1.5 M1.39 M1.2 M 5.53 M Discontinued operations ————— — Net income 981.03 K1.44 M1.5 M1.39 M1.2 M 5.53 M Dilution adjustment 964.03 K1.59 M1.61 M12.68 M0 15.88 M Preferred dividends 964.03 K1.59 M1.61 M12.68 M1.38 M 17.27 M Diluted net income available to common stockholders 981.03 K1.44 M1.5 M1.39 M-183.2 K 4.14 M Basic earnings per share (Basic EPS) 0.120.140.140.120.12 0.52 Diluted earnings per share (Diluted EPS) 0.120.140.140.120.12 0.52 Average basic shares outstanding 16.43 M19.04 M19.91 M20.29 M21.61 M — Diluted shares outstanding 16.43 M19.04 M19.91 M20.29 M21.61 M — EBITDA ————— — EBIT ————— — Cost of revenue ————— — Other cost of goods sold ————— — Depreciation & amortization (cash flow) ————— —